Literature DB >> 22545970

Contribution of vasoactive eicosanoids and nitric oxide production to the effect of selective cyclooxygenase-2 inhibitor, NS-398, on endotoxin-induced hypotension in rats.

Bahar Tunctan1, Belma Korkmaz, Tuba Cuez, C Kemal Buharalioglu, Seyhan Sahan-Firat, John Falck, Kafait U Malik.   

Abstract

Our previous studies with the use of non-selective cyclooxygenase (COX) inhibitor, indomethacin, demonstrated that prostanoids produced during endotoxaemia increase inducible nitric oxide synthase (iNOS) protein expression and nitric oxide synthesis, and decrease cyctochrome P450 (CYP) 4A1 protein expression and CYP 4A activity. The results suggest that dual inhibition of iNOS and COX by indomethacin restores blood pressure presumably due to increased production of 20-hydroxyeicosatetraenoic acid (20-HETE) derived from CYP 4A in endotoxaemic rats. The present study examined whether increased levels of vasoconstrictor eicosanoids, 20-HETE, prostaglandin F(2α) (PGF(2α) )and thromboxane A(2) (TxA(2) ), would contribute to the effect of selective COX-2 inhibition to prevent endotoxin (ET)-induced fall in blood pressure associated with an increase in the production of vasodilator prostanoids, prostaglandin I(2) (PGI(2) ) and prostaglandin E(2) (PGE(2) ) and nitric oxide synthesis. Mean arterial blood pressure fell by 31 mmHg and heart rate (HR) rose by 90 beats/min. in male Wistar rats treated with ET (10 mg/kg, i.p.). The fall in mean arterial pressure and increase in HR were associated with increased levels of 6-keto-prostaglandin F(1α) (6-keto-PGF(1α) ), PGE(2) , TxB(2) , and nitrite in the serum, kidney, heart, thoracic aorta and/or superior mesenteric artery. Systemic and renal 20-HETE and PGF(2α) levels were also decreased in endotoxaemic rats. These effects of ET were prevented by a selective COX-2 inhibitor, N-(2-cyclohexyloxy-4-nitrophenyl)methansulphonamide (10 mg/kg, i.p.), given 1 hr after injection of ET. These data suggest that an increase in 20-HETE and PGF(2α) levels associated with decreased production of PGI(2) , PGE(2) , and TxA(2) , and nitric oxide synthesis contributes to the effect of selective COX-2 inhibitor to prevent the hypotension during rat endotoxaemia.
© 2010 The Authors. Basic & Clinical Pharmacology & Toxicology © 2010 Nordic Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22545970      PMCID: PMC3128812          DOI: 10.1111/j.1742-7843.2010.00589.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  35 in total

1.  20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase.

Authors:  Voahanginirina Randriamboavonjy; Rudi Busse; Ingrid Fleming
Journal:  Hypertension       Date:  2002-12-16       Impact factor: 10.190

Review 2.  Regulation of the expression of inducible nitric oxide synthase.

Authors:  Hartmut Kleinert; Petra M Schwarz; Ulrich Förstermann
Journal:  Biol Chem       Date:  2003 Oct-Nov       Impact factor: 3.915

3.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

Authors:  L C Green; D A Wagner; J Glogowski; P L Skipper; J S Wishnok; S R Tannenbaum
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

4.  Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase. Formation and identification of novel endothelium-dependent vasoconstrictor metabolites.

Authors:  M L Schwartzman; J R Falck; P Yadagiri; B Escalante
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

5.  Indomethacin and alpha-tocopheral enhanced survival in endotoxic rats.

Authors:  R B Ashorobi; P A Williams
Journal:  Cent Afr J Med       Date:  1995-07

6.  Effects of cyclooxygenase inhibitors on nitric oxide production and survival in a mice model of sepsis.

Authors:  Bahar Tunçtan; Sedat Altug; Orhan Uludag; Beray Demirkay; Nurettin Abacioglu
Journal:  Pharmacol Res       Date:  2003-07       Impact factor: 7.658

7.  Role of cyclooxygenase in ventricular effects of adrenomedullin: is adrenomedullin a double-edged sword in sepsis?

Authors:  Shivani Mittra; Jean-Marc Hyvelin; Qixian Shan; Fai Tang; Jean-Pierre Bourreau
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-03       Impact factor: 4.733

8.  Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites.

Authors:  M A Carroll; M P Garcia; J R Falck; J C McGiff
Journal:  J Pharmacol Exp Ther       Date:  1992-01       Impact factor: 4.030

9.  Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase.

Authors:  B Escalante; W C Sessa; J R Falck; P Yadagiri; M L Schwartzman
Journal:  J Pharmacol Exp Ther       Date:  1989-01       Impact factor: 4.030

10.  20-hydroxyeicosatetraenoic acid is an endothelium-dependent vasoconstrictor in rabbit arteries.

Authors:  B Escalante; K Omata; W Sessa; S G Lee; J R Falck; M L Schwartzman
Journal:  Eur J Pharmacol       Date:  1993-04-22       Impact factor: 4.432

View more
  12 in total

1.  Bexarotene, a Selective RXRα Agonist, Reverses Hypotension Associated with Inflammation and Tissue Injury in a Rat Model of Septic Shock.

Authors:  Bahar Tunctan; Sefika P Kucukkavruk; Meryem Temiz-Resitoglu; Demet S Guden; Ayse N Sari; Seyhan Sahan-Firat
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

2.  NS-398 reverses hypotension in endotoxemic rats: contribution of eicosanoids, NO, and peroxynitrite.

Authors:  Bahar Tunctan; Ayse Nihal Sari; Meltem Kacan; Demet Unsal; C Kemal Buharalioglu; Seyhan Sahan-Firat; Belma Korkmaz; John R Falck; Kafait U Malik
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-09-05       Impact factor: 3.072

3.  The renal vasodilatory effect of prostaglandins is ameliorated in isolated-perfused kidneys of endotoxemic mice.

Authors:  Manuel Meurer; Katharina Ebert; Frank Schweda; Klaus Höcherl
Journal:  Pflugers Arch       Date:  2018-07-19       Impact factor: 3.657

4.  Piroxicam reverses endotoxin-induced hypotension in rats: contribution of vasoactive eicosanoids and nitric oxide.

Authors:  C Kemal Buharalioglu; Belma Korkmaz; Tuba Cuez; Seyhan Sahan-Firat; Ayse Nihal Sari; Kafait U Malik; Bahar Tunctan
Journal:  Basic Clin Pharmacol Toxicol       Date:  2011-05-06       Impact factor: 4.080

5.  20-Hydroxyeicosatetraenoic acid inhibits ATP-induced COX-2 expression via peroxisome proliferator activator receptor-α in vascular smooth muscle cells.

Authors:  Chan-Jung Liang; Ching-Ping Tseng; Chuen-Mao Yang; Yunn-Hwa Ma
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

Review 6.  An eicosanoid-centric view of atherothrombotic risk factors.

Authors:  Scott Gleim; Jeremiah Stitham; Wai Ho Tang; Kathleen A Martin; John Hwa
Journal:  Cell Mol Life Sci       Date:  2012-04-11       Impact factor: 9.261

7.  Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock.

Authors:  Bahar Tunctan; Belma Korkmaz; Ayse Nihal Sari; Meltem Kacan; Demet Unsal; Mehmet Sami Serin; C Kemal Buharalioglu; Seyhan Sahan-Firat; Tuba Cuez; Wolf-Hagen Schunck; Vijaya L Manthati; John R Falck; Kafait U Malik
Journal:  Nitric Oxide       Date:  2013-05-14       Impact factor: 4.427

8.  Liposomal co-delivered oleanolic acid attenuates doxorubicin-induced multi-organ toxicity in hepatocellular carcinoma.

Authors:  Muhammad Sarfraz; Attia Afzal; Shahid Masood Raza; Sajid Bashir; Asadullah Madni; Muhammad Waseem Khan; Xiang Ma; Guangya Xiang
Journal:  Oncotarget       Date:  2017-07-18

9.  The Characterization of Ground Raspberry Seeds and the Physiological Response to Supplementation in Hypertensive and Normotensive Rats.

Authors:  Michał Majewski; Ewa Kucharczyk; Roman Kaliszan; Michał Markuszewski; Bartosz Fotschki; Jerzy Juśkiewicz; Małgorzata Borkowska-Sztachańska; Katarzyna Ognik
Journal:  Nutrients       Date:  2020-06-01       Impact factor: 5.717

Review 10.  Prostaglandins in the pathogenesis of kidney diseases.

Authors:  Yuanyuan Li; Weiwei Xia; Fei Zhao; Zhaoying Wen; Aihua Zhang; Songming Huang; Zhanjun Jia; Yue Zhang
Journal:  Oncotarget       Date:  2018-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.